# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-004105
Filing Date
2018-03-01
Accepted
2018-03-01 16:10:53
Documents
91
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | nktr-10k_20171231.htm | 10-K | 3429060
2 | EX-10.9 | nktr-ex109_195.htm | EX-10.9 | 292082
3 | EX-10.18 | nktr-ex1018_184.htm | EX-10.18 | 52177
4 | EX-21.1 | nktr-ex211_7.htm | EX-21.1 | 5519
5 | EX-23.1 | nktr-ex231_8.htm | EX-23.1 | 3978
6 | EX-31.1 | nktr-ex311_9.htm | EX-31.1 | 8178
7 | EX-31.2 | nktr-ex312_6.htm | EX-31.2 | 8160
8 | EX-32.1 | nktr-ex321_10.htm | EX-32.1 | 7653
9 | GRAPHIC | g2018030120260199130401.jpg | GRAPHIC | 2094
10 | GRAPHIC | g2018030120255838228798.jpg | GRAPHIC | 44855
| Complete submission text file | 0001564590-18-004105.txt |  | 12048126

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL INSTANCE DOCUMENT | nktr-20171231.xml | EX-101.INS | 2456527
12 | XBRL TAXONOMY EXTENSION SCHEMA | nktr-20171231.xsd | EX-101.SCH | 95581
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nktr-20171231_cal.xml | EX-101.CAL | 79123
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nktr-20171231_def.xml | EX-101.DEF | 283224
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nktr-20171231_lab.xml | EX-101.LAB | 648019
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nktr-20171231_pre.xml | EX-101.PRE | 487268

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 18657375
SIC: 2834 Pharmaceutical Preparations